Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis, Chronic

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects

NCT00807001

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C (HCV), +15 more
Locations: Not specified

View Trial Details

Completed

Telaprevir Open-Label Study in Co-Infected Patients

NCT01500616

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Antwerp, Belgium

Brussels, Belgium

Charleroi, Belgium

Ghent, Belgium

View all 29 locations

View Trial Details

Completed

A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon

NCT01531166

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Sang Hoon Ahn Seoul, Seodaemun-gu, South Korea

View Trial Details

Completed

Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus

NCT02761629

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Campinas, Brazil

Florianópolis, Brazil

Itajaí, Brazil

Juiz de Fora, Brazil

View all 17 locations

View Trial Details

Completed

A Quality of Life Study of Peginterferon-Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C and Persistently Normal Alanine Transaminase (ALT) Levels

NCT02726022

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Aigaleo - Attiki, Greece

Athens, Greece

Athens, Greece

Athens, Greece

View Trial Details

Completed

A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment

NCT02864199

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Birmingham, Alabama, United States

Kansas City, Kansas, United States

New Orleans, Louisiana, United States

Kansas City, Missouri, United States

View all 17 locations

View Trial Details

Completed

Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue

NCT01480284

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Aichi, Japan

GSK Investigational Site Aichi, Japan

GSK Investigational Site Chiba, Japan

GSK Investigational Site Fukui, Japan

View all 32 locations

View Trial Details

Completed

PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

NCT01066819

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Birmingham, Alabama, United States

Birmingham, Alabama, United States

Birmingham, Alabama, United States

Dothan, Alabama, United States

View all 106 locations

View Trial Details

Completed

A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

NCT01482403

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Littleton, Colorado, United States

Chicago, Illinois, United States

Shreveport, Louisiana, United States

Detroit, Michigan, United States

View all 24 locations

View Trial Details

Completed

A Study of Peginterferon Alfa-2a (Pegasys) When Administered in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC)

NCT02641379

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Feldkirch, Austria

Gratwein, Austria

Graz, Austria

Graz, Austria

View all 21 locations

View Trial Details